» Articles » PMID: 14739095

Systemic Inflammatory Response Exacerbates the Neuropsychological Effects of Induced Hyperammonemia in Cirrhosis

Overview
Journal J Hepatol
Publisher Elsevier
Specialty Gastroenterology
Date 2004 Jan 24
PMID 14739095
Citations 186
Authors
Affiliations
Soon will be listed here.
Abstract

Background/aims: Studies in acute liver failure show correlation between evidence of a systemic inflammatory response syndrome (SIRS) and progression of hepatic encephalopathy (HE). We tested the hypothesis that SIRS mediators, such as nitric oxide and proinflammatory cytokines, may exacerbate the neuropsychological effects of hyperammonemia in cirrhosis.

Methods: Ten patients with cirrhosis were studied, 24-36 h after admission with clinical evidence of infection, and following its resolution. Hyperammonemia was induced by oral administration of an amino-acid (aa) solution mimicking hemoglobin composition. Inflammatory mediators, nitrate/nitrite, ammonia, aa profiles and a battery of neuropsychological tests were measured.

Results: The hyperammonemia generated in response to the aa solution was similar prior to, and after resolution, of the inflammation (P=0.77). With treatment of the infection there were significant reductions in white blood cell count (WBC), C-reactive protein (CRP), nitrate/nitrite, interleukin-6, interleukin-1beta and tumour necrosis factor alpha. Induced hyperammonemia resulted in significant worsening of the neuropsychological scores when patients showed evidence of SIRS but not after its resolution.

Conclusions: The significant deterioration of neuropsychological test scores following induced hyperammonemia during the inflammatory state, but not after its resolution, suggests that the inflammation and its mediators may be important in modulating the cerebral effect of ammonia in liver disease.

Citing Articles

Bacterial Meningitis Associated With Spontaneous Bacterial Peritonitis Caused by Escherichia coli in a Patient With Alcoholic Liver Cirrhosis.

Umemoto D, Nishioka H Cureus. 2025; 17(1):e77937.

PMID: 39996229 PMC: 11847634. DOI: 10.7759/cureus.77937.


Vitamin D Supplementation Is Associated with Inflammation Amelioration and Cognitive Improvement in Decompensated Patients with Cirrhosis.

Diaz-Ruiz R, Poca M, Roman E, Panadero-Gomez R, Cuyas B, Banares I Nutrients. 2025; 17(2.

PMID: 39861356 PMC: 11768058. DOI: 10.3390/nu17020226.


Ammonia and beyond - biomarkers of hepatic encephalopathy.

Gallego J, Ballester M, Fiorillo A, Casanova-Ferrer F, Lopez-Gramaje A, Urios A Metab Brain Dis. 2025; 40(1):100.

PMID: 39812958 PMC: 11735499. DOI: 10.1007/s11011-024-01512-7.


Activation of the kynurenine pathway identified in individuals with covert hepatic encephalopathy.

Zeng G, Krishnamurthy S, Staats Pires A, Guller A, Chaganti J, Tun N Hepatol Commun. 2025; 8(12.

PMID: 39774873 PMC: 11567712. DOI: 10.1097/HC9.0000000000000559.


A novel sweat sensor detects inflammatory differential rhythmicity patterns in inpatients and outpatients with cirrhosis.

Davis B, Lin K, Shahub S, Ramasubramanya A, Fagan A, Muthukumar S NPJ Digit Med. 2024; 7(1):382.

PMID: 39733165 PMC: 11682110. DOI: 10.1038/s41746-024-01404-1.